Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL
Clinical trial NCT03863184 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03863184
- Sponsor
- Weill Medical College of Cornell University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-11
- Primary completion
- 2024-04-25
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.